Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Wearable Devices Help Enact Transformative Changes in the Healthcare Space

Wearable technology is designed to detect, analyze, and transmit information concerning body signals such as vital signs, and/or ambient data. Wearable technology has a variety of applications, which grows as the field itself expands. It appears prominently in consumer electronics with the popularization of the smartwatch and activity tracker. In the healthcare setting, wearable sensing and information and communication technologies are key enablers driving the transformation of health care delivery toward a new model of connected health (CH) care. The future design and development of digital technology in this space will rely on continued analysis of best practices, pain points, and potential solutions to mitigate existing challenges within the healthcare infrastructure. Overall, the wearable medical devices market value is projected to reach USD 14.41 Billion by 2022 from USD 6.22 Billion in 2017 while expanding at a Compound Annual Growth Rate (CAGR) of 18.3%, according to a report by MarketsandMarkets. Nemaura Medical, Inc., Abbott Laboratories, Garmin Ltd., Fitbit, Inc.  Livongo Health, Inc.

Recommended AI News: Chris Porritt, Former VP At Tesla Joins Rimac Automobili As CTO

Traditionally, patient monitoring devices were used in hospitals to monitor a patient’s vital signs. Nowadays, with the advancements in wireless technology, these devices can be used to remotely monitor a patient’s various physiological parameters. In addition, new wearable monitoring devices, equipped with the Internet of Things (IoT) technology, are able to communicate with smartphones, transferring crucial data to right to user friendly applications. Besides technological advancements, other driving factors for the growth of the patient monitoring devices market include the rise in the prevalence of lifestyle diseases such as diabetes, cancer, and atherosclerosis, and of course the current pandemic has caused a spike in demand. The resurgence of medical devices that help consumers monitor their vital signs has also attracted the FDA’s attention. According to MedCity News, Courtney Lias, Director of the Division of Chemistry and Toxicology Devices Office, part of FDA’s Center for Devices and Radiological Health, spoke strongly in support of developing interoperable devices that could wirelessly communicate, not only with each other, but with other digital apps as well. “We want to incentivize interoperability and open systems through optimized regulatory pathways,” Lias said, noting that the agency has taken two regulatory actions to create a “pathway for devices to become integrated with each other including apps.”

Recommended AI News: Cloudian Integration With Splunk SmartStore Enables Swiss Financial Institution To Index And Store More Data At Lower Cost

Nemaura Medical, Inc. announced yesterday breaking news that, “it has commissioned the integration of data from third party wearable devices into its proBEAT™ app which is planned for launch in the USA later this year.

proBEAT™ is a wearable non-invasive glucose monitor designed to gather big data about the multitude of factors that affect blood glucose levels, based on which predictive algorithms and artificial intelligence-based feedback and prompts can be provided to users. The aim is to empower users with feedback of factors that could affect their blood glucose levels. The inclusion of data from third party wearable fitness devices is a significant development and expected to enable the relationship between various activities and factors affecting blood glucose levels to be compared side by side, thus further empowering and educating users of the proBEAT™ device and app in due course.

About Nemaura Medical, Inc.: is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT® , and proBEAT. sugarBEAT® , a CE mark approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor (CGM) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which may help people with diabetes and pre-diabetes to better manage, reverse and prevent the onset of diabetes. Nemaura has also submitted a PMA application for sugarBEAT® to the U.S. FDA. proBEAT™ comprises a non-invasive glucose monitor and a digital healthcare subscription service and is due to be launched in the US as a general wellness product.”

2 Comments
  1. […] Source: Wearable Devices Help Enact Transformative Changes in the Healthcare Space […]

Leave A Reply

Your email address will not be published.